Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

SUPNSUPN
13 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in SUPERNUS PHARMACEUTICALS

Point72 Asset Management, L.P. holds 1.3M shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $68.2M as of 2026-Q1. The position was decreased (-41.8% shares). SUPN represents 0.1% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$68.2M

Current Shares

1.3M

Total Value Change

+$61.9M

Total Shares Change

+971,889

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.3M
-41.8%
$68.2M0.1%$54.56
0
2025-Q4
Increased
2.3M
+28.6%
$112.6M0.1%$49.89
45
2025-Q3
Increased
1.8M
+246.9%
$84.2M0.1%$47.60
57
2025-Q2
Increased
507,790
+59.2%
$16M0.0%$31.16
40
2025-Q1
Increased
318,903
+1088.7%
$10.4M0.0%$32.29
45
2024-Q4
New
26,828
-
$970,0870.0%$36.91
35
2024-Q3
Exited
0
-100.0%
$00.0%$30.75
0
2024-Q2
Increased
136,342
+6.7%
$3.6M0.0%$26.75
28
2024-Q1
New
127,821
-
$4.4M0.0%$34.11
37
2023-Q2
Exited
0
-100.0%
$00.0%$29.91
0
2023-Q1
New
755
-
$27,3540.0%$36.27
27
2020-Q2
Exited
0
-100.0%
$00.0%$23.27
0
2020-Q1
New
346,666
-
$6.2M0.1%$17.16
38

Other major holders of SUPN: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used